Delivery Order SPE2DB24D2205-SPE2DB25FEJBV
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $20,643.53 by the Defense Logistics Agency (DLA) on August 13, 2025, with an ultimate completion date of August 14, 2025. The delivery order, issued under contract 4569085162, is for Wezlana 90 mg/ml syringes and represents a non-set-aside, competitively awarded contract with firm fixed pricing. This award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $519,807.48 on September 10, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $283,325.74 by the Defense Logistics Agency's Medical Supply Chain on June 4, 2025, with an ultimate completion date of June 5, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract that leverages AmerisourceBergen's extensive pharmaceutical and medical supply distribution capabilities to support federal medical procurement needs. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $93,790.80 on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, was competitively awarded with no set-aside designation. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,447.93 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a competitively awarded, non-set-aside contract. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $57,029.60 by the Defense Logistics Agency's Medical Supply Chain. The contract, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $37,140.48 by the Defense Logistics Agency's Medical Supply Chain on July 9, 2025, with a completion date of July 10, 2025. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,379.98 on July 14, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract (4568779085) is scheduled for completion by July 15, 2025, and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $744,629.90 on September 13, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, with an ultimate completion date of September 15, 2025, operates as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded...
- AmerisourceBergen Drug Corp was awarded a $16,721.61 delivery order by the Defense Logistics Agency (DLA) for Wezlana 90 mg/ml syringes, with an ultimate completion date of April 22, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a tactical procurement of pharmaceutical supplies to support federal medical supply chain...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEJBVDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $45,196.15 by the Defense Logistics Agency on September 25, 2025, with an ultimate completion date of September 26, 2025. The contract covers the supply of Wezlana 90 mg/mL syringes and is structured as a firm fixed price delivery order with no set-aside designation. This award represents a competitive procurement under an existing contract vehicle, demonstrating AmerisourceBergen's continued role as a critical supplier of pharmaceutical products to the federal government's medical supply chain. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the contractor to supply a broad range of pharmaceutical products, specialty medications, vaccines, and medical supplies to support military healthcare programs globally, including services to the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates its established capability to fulfill diverse medical procurement requirements through open competition across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.2k | 9/25/25 |